Glaucoma treatment Market 2018 Growth, COVID Impact, Trends Analysis Report 2023

The Glaucoma is one of the major eyes disorders which causes damage to the optic nerve. Glaucoma can result in vision loss and blindness. There are various drugs used for the diagnosis of this disease. Some of them are Beta blocker, Alpha-adrenergic agonists, Hyperosmotics, and Carbonic anhydrase inhibitors. The global glaucoma treatment market is emerging with a rapid speed due to some of the major factors such as growing incidences of glaucoma diseases across the globe. Increasing old age population in various regions has become one of the reasons for the growth of this market. Various initiatives by the government and healthcare institutions in order to cure glaucoma related problems have helped for the growth of this segment. The market is also driven by favourable reimbursement policies related to glaucoma treatment.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/glaucoma-treatment-market

The continuous innovations in the drugs and rising number of patients with diabetes have resulted in significant growth opportunities. Although there are some factors which hinders the growth of market. This comprise of lack of awareness about the disease and its treatment in various developing and underdeveloped regions, and postoperative complications resulting after glaucoma surgery.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/glaucoma-treatment-market

Global glaucoma treatment market is studied on the basis of three segments: products, disease indication, end user and drug class. Based on the product, the market is further subdivided as glaucoma drainage devices, implants and stents and glaucoma laser devices. On the basis of disease indication, the market is sub-segmented as closed angle glaucoma, open angle glaucoma, congenital glaucoma and secondary glaucoma. The open angle glaucoma (OAG) and closed angle glaucoma (CAG) are the most common types of glaucoma. According to the International Council of Ophthalmology report, open angle and closed angle glaucoma individually account for about half of all glaucoma cases. In addition, they are responsible for the major cause of irreversible vision across the globe. Therefore, Open angle glaucoma and angle closure glaucoma segments are expected to have the highest share of glaucoma treatment market. Furthermore, according to the end user, the market is bifurcated as hospitals, eye care clinics and home care. According to the drug class, the market is diversified as prostaglandin analogues, alpha agonist, cholinergic, beta blockers and carbonic anhydrase inhibitors.

MARKET SEGMENTATION
BY PRODUCTS
• GLAUCOMA DRAINAGE DEVICES
• IMPLANTS AND STENTS
• GLAUCOMA LASER DEVICES
BY DISEASE INDICATION
• CLOSED ANGLE GLAUCOMA (CAG)
• OPEN ANGLE GLAUCOMA (OAG)
• SECONDARY GLAUCOMA
• CONGENITAL GLAUCOMA
BY END USER
• HOSPITALS
• EYE CARE CLINICS
• HOME CARE
BY DRUG CLASS
• PROSTAGLANDIN ANALOGUES
• ALPHA AGONIST
• CHOLINERGIC
• BETA BLOCKERS
• CARBONIC ANHYDRASE INHIBITORS

COMPETITIVE LANDSCAPE
• KEY MARKET STRATEGIES
• KEY COMPANY ANALYSIS

REGIONAL ANALYSIS
NORTH AMERICA
• UNITED STATES
• CANADA
• REST OF NORTH AMERICA
EUROPE
• UNITED KINGDOM
• FRANCE
• GERMANY
• ITALY
• SPAIN
• REST OF EUROPE
ASIA PACIFIC
• INDIA
• CHINA
• JAPAN
REST OF THE WORLD

COMPANY PROFILES
• AERIE PHARMACEUTICALS INC.
• AKORN, INC.
• ALLERGAN PLC
• BAUSCH & LOMB INCORPORATION
• BAYER AG
• CARL ZEISS AG
• F. HOFFMANN-LA ROCHE, LTD.
• HOYA CORPORATION
• INOTEK PHARMACEUTICALS CORPORATION
• IVANTIS, INC.
• JOHNSON & JOHNSON
• MERCK & CO., INC.
• NOVARTIS INTERNATIONAL AG
• PFIZER, INC.
• REGENERON PHARMACEUTICALS, INC.
• SANOFI S.A.
• SANTEN PHARMACEUTICALS CO., LTD.
• TEVA PHARMACEUTICALS INDUSTRIES, LTD.
• TOPCON CORPORATION
• VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
• SUNWAYS

Reasons to Buying From us –
• We cover more than 15 major industries, further segmented into more than 90 sectors.
• More than 120 countries are for analysis.
• Over 100+ paid data sources mined for investigation.
• Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/glaucoma-treatment-market

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.